Canadian College of Neuropsychopharmacology

CCNP Award Winners

Dr. Martin Alda is the recipient of the 2020 Canadian College of Neuropsycho-pharmacology (CCNP) Heinz Lehmann Award. The award recognizes the outstanding contributions and distinguished career by a single individual in the field of research in neuropsychopharmacology in Canada, and this year is being awarded for clinical research. The award, donated by Pfizer Canada Inc., consists of a $2,000 honorarium and a suitably engraved plaque. Congratulations to Dr. Alda!

Dr. Jeffrey Meyer is the recipient of the 2020 CCNP Innovations in Neuropsycho-pharmacology Award. The award recognizes innovative research in neuropsychopharma-cology by an independent investigator, and is being given this year for clinical research. The award, donated by Pfizer Canada Inc., consists of a $2,000 honorarium and a suitably engraved plaque. Congratulations to Dr. Meyer!

Dr. Beverley Orser is the recipient of the 2020 CCNP Medal. This award, sponsored by the CCNP, recognizes an individual for their meritorious career in, and outstanding contribution to, neuropsychopharmacology in Canada based on their activities in education, administration and/or patient care. The award consists of a bronze medal engraved with the name of the recipient. Congratulations to Dr. Orser!

Dr. Caroline Menard is the recipient of the 2020 CCNP Young Investigator Award. The award is being given this year for basic research. The award, donated by Pfizer Canada Inc., recognizes outstanding contributions to research in neuropsycho-pharmacology and consists of a $2,000 honorarium and a suitably engraved plaque. Congratulations to Dr. Menard!

Aims and Objectives of the College

The principal function of the Canadian College of Neuropsychopharmacology (CCNP) is to further research and education in neuropsychopharmacology and related fields. To achieve this function, the CCNP values open communication between membership and leadership related to governance of the CCNP, and encourages its members to support integrity, collegiality, and ethics in research. The CCNP is committed to maintaining a level of excellence in the conduct of science, supporting discovery and scientific dialogue within an environment that encourages the free expression and exchange of scientific and educational ideas. The CCNP has a tradition of providing a forum for exchange of scientific information between clinical and basic scientists, which is critical for the advancement and translation of scientific discovery in neuropsychopharmacology.

Mission

The aim of the College shall be:

a) to provide a forum for clinical and basic science researchers to discuss and exchange ideas and experience in neuropsychopharmacology and to promote the development of this science nationally and internationally.

b) to be a liaison body to educational institutions, public, industry and government organizations as well as other related scientific bodies in order to promote quality of research and treatment in this field.

Journal of Psychiatry & Neuroscience

The official journal of the Canadian College of Neuropsychopharmacology

The Journal of Psychiatry & Neuroscience has an impact factor of 4.899 (2018 ISI data) and is ranked at #22 out of 146 Psychiatry journals and #52 out of 267 Neuroscience journals.
Original research and reviews in basic and clinical science.
Articles published in the journal are available free of charge at http://jpn.ca and through PubMed Central.

For more information, visit the website of the Canadian Medical Association.

Revue de psychiatrie & de neuroscience

La revue officielle du Collège canadien de neuropsychopharmacologie

Le facteur d'impact de la Revue de psychiatrie et de neuroscience atteint 4,899 (données 2018 de l'ISI), ce qui en fait le journal à accès libre le mieux coté aussi bien dans la catégorie psychiatrie que dans la catégorie neurosciences.
Recherche originale et analyses critiques en sciences
fondamentales et cliniques.
Les articles publiés dans ce journal sont accessibles gratuitement au http://jpn.ca/ et via PubMed Central.

Pour obtenir des informations suplémentaires, visitez le site internet de l'Association Médicale Canadienne.